These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30567364)

  • 1. Investigation of the Compressibility and Compactibility of Titanate Nanotube-API Composites.
    Sipos B; Pintye-Hódi K; Regdon G; Kónya Z; Viana M; Sovány T
    Materials (Basel); 2018 Dec; 11(12):. PubMed ID: 30567364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as new drug carrier systems.
    Sipos B; Pintye-Hódi K; Kónya Z; Kelemen A; Regdon G; Sovány T
    Int J Pharm; 2017 Feb; 518(1-2):119-129. PubMed ID: 28027919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the drug deformation behaviour on the predictability of compressibility and compactibility of binary mixtures.
    Wünsch I; Finke JH; John E; Juhnke M; Kwade A
    Int J Pharm; 2022 Oct; 626():122117. PubMed ID: 35985527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of tabletting speed on compactibility and compressibility of two direct compressible powders under high speed compression.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1987-92. PubMed ID: 2268901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K; Picker-Freyer KM
    Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
    Hirschberg C; Sun CC; Rantanen J
    J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compressibility and compactibility of different types of lactose.
    Ilić I; Kása P; Dreu R; Pintye-Hódi K; Srcic S
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1271-80. PubMed ID: 19466896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compressibility and compactibility study of real tableting mixtures: the effect of granule particle size.
    Šantl M; Ilić I; Vrečer F; Baumgartner S
    Acta Pharm; 2012 Nov; 62(3):325-40. PubMed ID: 23470346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA; Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified equation for particle bonding area and strength with inclusion of powder fragmentation propensity.
    Lamešić D; Planinšek O; Ilić IG
    Eur J Pharm Sci; 2018 Aug; 121():218-227. PubMed ID: 29857044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percolation theory and compactibility of binary powder systems.
    Blattner D; Kolb M; Leuenberger H
    Pharm Res; 1990 Feb; 7(2):113-7. PubMed ID: 2308890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of compressibility and compactibility parameters of roller compacted Theophylline and its binary mixtures.
    Hadžović E; Betz G; Hadžidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2011 Sep; 416(1):97-103. PubMed ID: 21704142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the Production Process and Product Quality of Titanate Nanotube-Drug Composites.
    Ranjous Y; Regdon G; Pintye-Hódi K; Varga T; Szenti I; Kónya Z; Sovány T
    Nanomaterials (Basel); 2019 Oct; 9(10):. PubMed ID: 31581711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study.
    Schaller BE; Moroney KM; Castro-Dominguez B; Cronin P; Belen-Girona J; Ruane P; Croker DM; Walker GM
    Int J Pharm; 2019 Jul; 566():615-630. PubMed ID: 31158454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of compression as a potential process control tool of tablet tensile strength.
    Nordström J; Alderborn G
    Pharm Dev Technol; 2011; 16(6):599-608. PubMed ID: 20649411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A compression behavior classification system of pharmaceutical powders for accelerating direct compression tablet formulation design.
    Dai S; Xu B; Zhang Z; Yu J; Wang F; Shi X; Qiao Y
    Int J Pharm; 2019 Dec; 572():118742. PubMed ID: 31648016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compression physics in the formulation development of tablets.
    Patel S; Kaushal AM; Bansal AK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(1):1-65. PubMed ID: 16749898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On Identification of Critical Material Attributes for Compression Behaviour of Pharmaceutical Diluent Powders.
    Zhang J; Wu CY; Pan X; Wu C
    Materials (Basel); 2017 Jul; 10(7):. PubMed ID: 28773204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.